Lance Berman, Chief Medical Officer and SVP at Relypsa Inc (RLYP), sold 20,000 shares at $26.48 ($518K) on 2014-08-25, disclosed to the SEC on 2014-08-26.
Scheduled sale ($518k) by Chief Medical Officer and SVP under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $25.69 | 15,000 | $385K | 74.4% |
| 2 | $26.48 | 5,000 | $132K | 25.6% |
| Total | $25.89 avg | 20,000 | $518K | 100% |
| Filing → |
| RLYP | SELL | 2015-02-25 | $191K | — | Filing → |
| RLYP | SELL | 2014-12-02 | $125K | — | Filing → |
| RLYP | SELL | 2014-11-26 | $750K | — | Filing → |